baber/WOPTO huggingface dataset:
Patent DK-0537695-T3 (DK)
Inventor: MOEBIUS WERNER DIPL-ING
IPC: E02F5/00
Filed: 1992-10-14
Granted: 1996-08-19
Abstract: A method of removing and placing sediments, sludge or other materials from/on the bed of a stretch of water, in which a hood-like receiving device is lowered onto the bed of the stretch of water and during the removal is pressed at least partly into the bed while material to be removed is enclosed, whereupon the water is displaced out of the receiving device and the enclosed material is removed from the bed of the stretch of water, is to bring about in particular better separation of the material to be removed, from the free water and is to be less complicated. To this end, the receiving device is closed at the bottom after being pressed into the bed and, to remove the enclosed material, is raised with the latter. On the other hand, during the placing of materials, the receiving device is brought through the water together with the enclosed material onto the bed of the stretch of water. After the bottom closure plate (11) is opened, the material can be pressed out of the receiving device by means of the pressure plate (6) and be deposited compactly on the bottom. <IMAGE>
Patent DK-0564494-T3 (DK)
Inventor: GOGSTAD GEIR OLAV
IPC: G01N33/553
Filed: 1991-12-21
Granted: 1995-03-06
Abstract: PCT No. PCT/EP91/02519 Sec. 371 Date Apr. 29, 1993 Sec. 102(e) Date Apr. 29, 1993 PCT Filed Dec. 21, 1991 PCT Pub. No. WO92/11537 PCT Pub. Date Jul. 9, 1992Methods of assaying samples for the presence of an analyte involving immobilization of a gold sol, and optionally an enzyme capable of generating a reaction product, on a solid phase. The gold sol has a mean particle size of less than 20 nm for at least 75% by weight of the particles and is formed into a novel superaggregated complex with at least one protein.
Patent DK-0578774-T3 (DK)
Inventor: LIN NANCY
IPC: A61K47/48
Filed: 1992-04-03
Granted: 1999-04-26
Abstract: The present invention relates to monoclonal antibodies specific for a cell receptor specific for human stem cell factor (hSCF) as well as pharmaceutical compositions containing such monoclonal antibodies and uses of such monoclonal antibodies.
Patent DK-0607278-T3 (DK)
Inventor: WILMORE DOUGLAS
IPC: A61P3/00
Filed: 1992-10-07
Granted: 2002-06-17
Abstract: The present invention provides a method for enhancing the gut absorption in a mammal. Specifically, gut absorption in a mammal can be enhanced by the administration of glutamine, or glutamine equivalent, in combination with one or more agents, said agents selected from the group consisting of growth hormone (GH), an agent capable of enhancing endogenous GH production, insulin like growth factor 1 (IGF-1), or an agent capable of enhancing endogenous IGF-1 production.
Patent DK-0590143-T3 (DK)
Inventor: SEIBOLD GUENTER
IPC: E04F13/21
Filed: 1993-04-07
Granted: 1996-02-26
Abstract: The bracket for repairing an attachment of an outer facade element to a load-bearing concrete member includes a flange attachable to the load-bearing concrete member; a supporting arm attached to the flange and provided with a longitudinal slot; and a jack mountable in the longitudinal slot in the supporting arm for support of the outer facade element. The jack is adjustably positionable in the longitudinal slot of the supporting arm in a longitudinal direction of the supporting arm to compensate for different spacings of the outer facade element from the load-bearing concrete member. The jack includes a threaded bolt having a head, a bearing plate attached to the head for bearing on the outer facade element and a support plate secured to the bolt and bearing on the supporting arm. The bearing plate is arched transversely to the longitudinal direction of the supporting arm so as to be engagable with a curved surface of a hole drilled in the outer facade element.
Patent DK-0652794-T3 (DK)
Inventor: SCHAPER HUBERTUS CORNELIS J
IPC: A63B41/08
Filed: 1993-07-09
Granted: 1996-03-18
Abstract: An inflatable ball for ball games comprises an outer ball having interconnected parts consisting of twelve equilateral pentagons (1) and twenty equiangular hexagons (2). Each pentagon (1) is enclosed by five hexagons (2) and at the location of the connection between a pentagon (1) and a hexagon (2) the sides connected to one another are of equal length. In order to minimise, and preferably reduce to zero, the difference in stress in the material of the hexagons (2) and pentagons (1) when the ball is in the inflated state, each of the hexagons (2) has three sides (a) of relatively great length connected to a pentagon (1), and three sides (b) of relatively small length connected to a hexagon (2), the length of the short sides (b) being at least 0.69 times the length of the long sides (a), preferably, b = 0.839 a.
Patent DK-0652766-T3 (DK)
Inventor: O'CONNOR BARBARA H
IPC: A61K38/27
Filed: 1993-07-29
Granted: 2001-01-29
Abstract: A stable pharmaceutically acceptable aqueous formulation containing human growth hormone, a buffer, a non-ionic surfactant, and, optionally, a neutral salt, mannitol, or, a preservative, is disclosed. Also disclosed are associated means and methods for preparing, storing, and using such formulations.
Patent DK-0656872-T3 (DK)
Inventor: ANDERSSON KJELL
IPC: C01B33/149
Filed: 1993-08-11
Granted: 1996-10-07
Abstract: PCT No. PCT/SE93/00663 Sec. 371 Date Feb. 3, 1995 Sec. 102(e) Date Feb. 3, 1995 PCT Filed Aug. 11, 1993 PCT Pub. No. WO94/05596 PCT Pub. Date Mar. 17, 1994Silica sols with a high content of microgel and particles with a specific surface area within the range 300 to 700 m2/g, preferably 400 to 650 m2/g. The sols can be prepared by acidification or a water glass solution and alkalization at a certain dry content, alternatively to a certain pH. The sols are particularly suitable for use as additives in papermaking in combination with cationic polymers and especially in combination with cationic acrylamide based polymers.
Patent DK-0615492-T3 (DK)
Inventor: BERNONI CLAUDIO
IPC: B60B37/00
Filed: 1993-09-29
Granted: 1996-09-02
Abstract: PCT No. PCT/IT93/00102 Sec. 371 Date Jun. 13, 1994 Sec. 102(e) Date Jun. 13, 1994 PCT Filed Jun. 29, 1993 PCT Pub. No. WO94/08802 PCT Pub. Date Apr. 28, 1994.An assembly for supporting axles of different diameters in a wheel, in which the wheel has a hub with a bushing receiving portion having an interior surface of a first diameter. The bushing has a portion with an outer surface of a second diameter, somewhat smaller than the hub first diameter, to fit axially into the hub receiving portion and an axle receiving portion having an inner surface of a third diameter that accepts an axle of a corresponding diameter. The hub bushing receiving portion has a first seating on its interior surface and the bushing outer surface has a second seating. A fixing element in the bushing second seating expands radially of the bushing into the hub first seating when the bushing is inserted axially into the hub bushing receiving portion and locks the bushing to the hub.
Patent DK-0669072-T3 (DK)
Inventor: CANNON GREGORY LEWIS
IPC: G08B5/22
Filed: 1993-10-14
Granted: 2003-05-26
Abstract: A selective call messaging peripheral (100) capable of receiving at least one message and communicating it to an electronic information processing device (200) comprises a microcontroller (105) including a processor (106) for executing a microcode program that controls operation of the peripheral and a receiver (103) that operates to receive and demodulate an information signal to provide a recovered information signal including an address signal and the message. A correlator (109) compares the recovered address signal with a predetermined address and generates an address detection, indicating selection of the peripheral. A PCMCIA memory only interface (119) communicates notification of address detection to the electronic information processing device (200), and in response to a message read command received from the electronic information processing device (200), the microcontroller (105) configures the Personal Computer Memory Card Interface Association (PCMCIA) interface (119) to permit the electronic information processing device (200) to read the message from the peripheral (100).
Patent DK-0655249-T3 (DK)
Inventor: RIESS DR GUENTER
IPC: C07H11/04
Filed: 1994-11-23
Granted: 2001-06-18
Abstract: Moenomycin and its derivatives are suitable for preparation of medicaments for the treatment of stomach ulcers and for the control of Helicobacter pylori.
Patent DK-0612763-T3 (DK)
Inventor: VILAINE JEAN-PAUL
IPC: A61P9/00
Filed: 1994-02-17
Granted: 1997-12-15
Abstract: The invention relates to the derivatives of formula (I): <IMAGE>  in which R1, R2, X1 and X2 are defined as in the description. Medicaments.
Patent DK-0650764-T3 (DK)
Inventor: LOMPECH HERVE
IPC: B05B1/34
Filed: 1994-11-03
Granted: 1998-09-23
Abstract: The invention relates to a spray device intended to be mounted on a fluid dispenser connected to a reservoir; of the type comprising a head (1) provided with an expansion chamber (10) into which emerges the ejection orifice of the said dispenser; and which communicates via at least one outlet conduit (11) with a nozzle (2). According to the invention, the said nozzle consists of an articulated internal element (21) which is, at least partially, housed in the outlet conduit (11) and of an external element (22) fixed so as to bear in a sealed manner against the said internal element (21) in order to define, between their respective surfaces in contact, a system of swirling (turbulence-creating) channels communicating with the outlet conduit (11) and emerging on the outside via a spray orifice (220) made through the external element (22). <IMAGE>
Patent DK-0654031-T3 (DK)
Inventor: MANSOUR TAREK S
IPC: C07D473/00
Filed: 1994-06-07
Granted: 2000-06-13
Abstract: PCT No. PCT/CA94/00311 Sec. 371 Date Feb. 2, 1995 Sec. 102(e) Date Feb. 2, 1995 PCT Filed Jun. 7, 1994 PCT Pub. No. WO94/29301 PCT Pub. Date Dec. 22, 1994The present invention relates to a process for producing predominantly pure cis nucleoside analogues of formula (I), wherein X is S, or O; Y is S, CH2, O or CH(R); wherein R is azido or halogen; and R2 is a purine or pyrimidine base; via the coupling of a silylated purine or pyrimidine base in the presence of an appropriate Lewis acid with a bicyclic intermediate of formula (III) wherein Z is S or O; followed by conversion of the resulting intermediate of formula (II) to an alkyl ester and reduction to yield a compound of formula (I).    <IMAGE>  (I)   <IMAGE>  (II)   <IMAGE>  (III)
Patent DK-0711289-T3 (DK)
Inventor: CHANG KWEN-JEN
IPC: A61P25/24
Filed: 1994-07-29
Granted: 2000-11-06
Abstract: Diarylmethyl piperazine compounds having utility as exogenous receptor combinant species for binding with receptors such as delta, mu, sigma, and/or kappa receptors are disclosed. Compounds of the invention may be employed as conjugates in agonist/antagonist pairs for transductional monitoring and assays of neurotransmitter function, and also variously exhibit therapeutic utility, including mediating analgesia, and possessing utility for the treatment of diarrhea, urinary incontinence, mental illness, drug and alcohol addiction/overdose, lung edema, depression, asthma, emphysema, cough, and apnea, respiratory depression, cognitive disorders, emesis and gastrointestinal disorders.
Patent DK-0711243-T3 (DK)
Inventor: SANCOFF GREGORY E
IPC: B05B11/00
Filed: 1994-08-08
Granted: 2000-05-29
Abstract: A liquid dispensing device (2) and a method of dispensing liquid are disclosed. The device (2) includes a hollow gas and liquid tight casing (4), a flexible gas and liquid tight membrane (18, 130) having at least one convolution (132) and disposed across the casing interior and dividing the interior into a propellant chamber (36) and a liquid chamber (24), an outlet port (28) from the liquid chamber (24), two mutually reactive chemicals (38, 40) in the propellant chamber (36) but reactive upon contact to form a propellant gas. Upon generation of the gas, the gas expands against the membrane (18, 130), pressurizing the liquid chamber (24) to expel the contained liquid through the outlet port (28). A pressure relief valve (45), suitable for use with the device, allows gas to escape from the device when the gas pressure exceeds a predetermined level.
Patent DK-0721419-T3 (DK)
Inventor: MEYNARD JOSEPH
IPC: B31B50/86
Filed: 1994-09-26
Granted: 1997-12-22
Abstract: PCT No. PCT/FR94/01117 Sec. 371 Date Jun. 24, 1996 Sec. 102(e) Date Jun. 24, 1996 PCT Filed Sep. 26, 1994 PCT Pub. No. WO95/09776 PCT Pub. Date Apr. 13, 1995The process for manufacturing an integrally-formed handle for a bag includes the steps of turning an edge of a sheet of bag stock on itself a predetermined number of times to form a multiple-thickness handle on the sheet stock, while leaving an adjacent portion of the sheet stock unfolded. The opposed side edge portions of the handle are then folded onto and overlying the unfolded portion of the sheet stock. The folded side edge portions are then glued onto the unfolded portion of the sheet stock. The central portion of the handle is then severed from the unfolded portion of the sheet stock. The unfolded portion of the sheet stock is then folded and glued into a bag enclosure with the handle residing adjacent a side of the bag defining a top opening.
Patent DK-0770039-T3 (DK)
Inventor: ADAMS BILLY J
IPC: B01J19/12
Filed: 1995-07-07
Granted: 2003-03-17
Abstract: A system for reducing biological organisms in a liquid effluent to non-viable organic molecules that includes: a stunning chamber that applies a voltage potential across biological organisms to break cell membranes and disable the defense mechanisms of vital organisms to ultraviolet radiation; a cavitation chamber to physically destroy any remaining membranes of biologicals in the effluent that may play host to vital organisms or allow such to hide therein, the action of the stunning and cavitation chambers releasing interferons; and a molecularly implanted stimulated emitter (MISE) chamber in which high levels of ultraviolet radiation are applied to virions and spores that remain at frequencies that are readily absorbed and operate to disassociate any viable DNA and RNA strands remaining, to thereby cause "death". Prior to the stunning chamber, preferably the effluent has any large solids therein, settled, floated or filtered out. When potable water is to be produced, heavy metals and other common inorganic contaminants are also removed. The resulting effluent is pulsed through the stunning, cavitation, and MISE chambers to gain maximum effect thereof. Once the DNA and RNA strands have been disassociated in the MISE chamber, the environment of the downstream flow is controlled to prevent reassociation of organic molecules into viable DNA or RNA strands by either diluting the output of the MISE chamber to such an extent that organic molecules are unlikely to recombine, or when drinking water is to be produced, by filtering the organic filtering the organic molecules out for cosmetic purposes.
Patent DK-0788518-T3 (DK)
Inventor: HADDLETON DAVID MARK
IPC: C09D7/12
Filed: 1995-10-09
Granted: 1999-12-27
Abstract: PCT No. PCT/GB95/02376 Sec. 371 Date Jul. 15, 1997 Sec. 102(e) Date Jul. 15, 1997 PCT Filed Oct. 9, 1995 PCT Pub. No. WO96/13527 PCT Pub. Date May 9, 1996Process for the free-radical polymerisation of olefinically unsaturated monomer(s) using a free-radical initiator, the polymerisation being performed in the presence of a compound for effecting molecular weight control, wherein the molecular weight control compound is a Co Il chelate of the following formula I wherein each group X, independently in each ring and in different rings, is a substituent selected from alkyl of 1 to 14 carbon atoms and cycloalkyl of 6 to 14 carbon atoms; n, independently in each ring, is 0 to 5 provided that in at least one ring, n is 1 to 5; Z, independently on each boron atom, is selected from F, Cl, Br, OH, alkoxy of 1 to 12 carbon atoms, aryloxy of 6 to 12 carbon atoms, alkyl of 1 to 12 carbon atoms, and aryl of 6 to 12 carbon atoms; or two Z groups taken together provide on one or both boron atoms a group -O-(Q)-O- where Q is a divalent aryl or alicyclic linking group or an alkylene linking group, or two Z groups taken together on one or both boron atoms provide a 1,5-cyclooctanediyl linking group; or being a Co III analogue of said Co II chelate of formula I in which the Co atom is additionally covalently bonded, in a direction at right angles to the macrocyclic chelate ring system, to H, halide or other anion, or a homolytically dissociable organic group; and wherein optionally at least one further ligand is coordinated to the CoII or CoIII atom, being a ligand which does not alter the Co valency state. Also the Co chelates used in the polymerisation process, a process for their production, and the use in various applications of oligomers made using the polymerisation process.
Patent DK-0826307-T3 (DK)
Inventor: WINKS ROBERT GORDON
IPC: A23K3/00
Filed: 1990-06-25
Granted: 2002-02-18
Abstract: Fumigation of grain in a storage facility having a plurality of grain silos (13) is effected from a single source (10) of a mixture of a carrier gas and a gaseous fumigant. The single source is connected to a single gas supply duct (11), to which gas inlet ports (16) of the silos are also connected. The connection between each gas inlet port and the duct is provided with a respective valve (14) and a respective orifice plate (15), which is adjusted so that the pressure drop across the orifice plate into the silo is substantially greater than the pressure drop across any other component between the gas source and the silo. With this arrangement, the flow rate of gaseous fumigant through the grain-containing silos in the facility suffers only a minor perturbation when a valve between the gas supply duct and a silo is opened or closed. This minor perturbation can be readily compensated by returning the gas pressure in the duct to its previous value. <IMAGE>
Patent DK-0791333-T3 (DK)
Inventor: TWYFORD ROBERT H JNR
IPC: A61B17/12
Filed: 1992-09-17
Granted: 2000-05-01
Abstract: A detachable pusher-vasoocclusive coil assembly (11) for use in occluding a selected site within a vessel, comprising in combination:       a vasoocclusive coil (13) having a proximal end; and   a pusher (12) having a distal end;     characterised in that: a first radial protuberance (16) is carried on the proximal end of the coil solely by means of a proximally extending wire (15); a second radial protuberance (20) is carried on the distal end of the pusher (12) solely by means of a distally extending wire (19); said radial protuberances (16,20) are adapted to be engaged by being axially overlapped and interlocked, with the first protuberance (16) positioned proximally of the second protuberance (20), with the proximally extending wire (15) extending axially past the second protuberance (20) and with the distally extending wire (19) extending axially past the first protuberance (16); and the assembly further comprises means (14,21) carried coaxially about the pusher (12) and coil (13) that is axially movable relative to the coil and pusher from a first position, in which the means radially encloses the engaged protuberances (16,20) to prevent them from substantial radial movement relative to each other to prevent their disengagement, to a second position in which the means does not radially enclose the protuberances and the protuberances are free to disengage.   <IMAGE>
Patent DK-0998315-T3 (DK)
Inventor: BEUTTENMUELLER MANFRED
IPC: A61M5/30
Filed: 1998-07-18
Granted: 2004-07-12
Abstract: Featured is a method for injection of a payload into the tissues of an organism or a body, including the steps of generating forces by electromagnetic repulsion and accelerating the payload to be injected, using the generated electromagnetic forces. The payload is thereby accelerated to a velocity sufficient for the payload to pass through the skin of the organism and be disposed in the subcutaneous tissues. The method further includes providing an electromagnetic force generating device that generates forces electromagnetically in a predetermined direction responsive to an electric current flowing through the device, wherein the step of generating includes passing an electric current through the electromagnetic force generating device to generate the electromagnetic repulsive forces used for accelerating the payload. Also featured is a electromagnetic force generating mechanism that includes a conductive member, which is configured so as to generate electromagnetic repulsive forces in a given direction to accelerate the payload responsive to a pulsed current passing through the conductive member. Additionally featured is an electromagnetic transdermal injection device including such an electromagnetic force generating mechanism, an electrical power supply and a switch that selectively interconnects the power supply and force generating mechanism to accelerate a payload such as a medicine.
Patent DK-0999747-T3 (DK)
Inventor: GUARNA ANTONIO
IPC: A01N43/90
Filed: 1998-07-29
Granted: 2003-08-11
Abstract: Disclosed are compositions of benzo(c)quinolizine derivatives and methods for promoting plant and seed growth. The compounds are benzo[c]quinolizine derivatives which exert an inhibiting effect on the 5-alpha-reductase enzymes. The compounds selectively affect the growth of plants, improving morphogenesis and development of commercially useful plants while acting as herbicides to inhibit weed development.
Patent DK-1088098-T3 (DK)
Inventor: GULNIK SERGEI V
IPC: C12Q1/37
Filed: 1999-06-23
Granted: 2011-06-20
Abstract: The present invention provides an assay for determining the biochemical fitness of a biochemical species in a mutant replicating biological entity relative to its predecessor. The present invention further provides a continuous fluorogenic assay for measuring the anti-HIV protease activity of protease inhibitor. The present invention also provides a method of administering a therapeutic compound that reduces the chances of the emergence of drug resistance in therapy.
Patent DK-1118170-T3 (DK)
Inventor: KETCHUM JOHN W
IPC: H04B7/26
Filed: 1999-10-01
Granted: 2010-10-11
Abstract: A method and apparatus for controlling the transmission of signals from one or more of a plurality of mobile stations (1300) to a base station (1400) on a plurality of M multiple access channels. A power control information packet formed from a plurality of power control bits is transmitted from the base station (1400) to the one or more mobile stations (1300). Each of the power control bits in the power control information packet has a position that is mapped to a selected access channel and to a time offset within the selected access channel. The power control information packet is received at a first mobile station (1300). A message is then transmitted from the first mobile station (1300) to the base station (1400) on a first access channel and at a first time offset associated with the first access channel. The message is transmitted from the first mobile station (1300) at a power level determined in response to a first power control bit in the power control information packet. The first power control bit is located in a first position in the power control information packet, the first position being mapped to the first access channel and the first time offset.